Research & Development

Research and Development Division:

Nuclear medicine is an indispensable specialty in modern medicine, which is firmly based on unshakable laws of mathematics and physics and continuous research and development is an integral part of the discipline. When the Institute of Nuclear Medicine was conceptualized, it was done with the aim of becoming a center of excellence in Nuclear Medicine techniques in the country. To reach that goal a division named “Research & Development Division” was formed in the National Institute of Nuclear Medicine & Allied Sciences (NINMAS) by the approval of Bangladesh Atomic Energy Commission (BAEC).
The main purpose of this division is to mobilize the research activities of this Institute, as well as to enhance the ongoing research activities. The broad objectives of the division are:
• To improve and upgrade Nuclear Medicine facilities at NINMAS.
• To stimulate and conduct research activities.
• To coordinate & standardize the activities of nuclear medicine services.
•To assist the ongoing research projects, research oriented paper submission and formulation/preparation research proposals.
• To archive all scientific works being done at the Institute.

Research & Development activities of NINMAS:

The institute has a significant volume of both large and small research and development programs. Development is a continuous process at the institute, which aims at upgrading the overall quality of nuclear medicine in the country. These include development of local manpower through post-graduate courses, orientation courses, training and workshops, quality control programs for technical procedures and instruments. Senior members of the institute deliver lectures to different courses of different universities as visiting part-time guest lecturers.

Research and development projects at NINMAS:

IAEA TC Project:
1. IAEA TC Project BGD/6/025 “Improving the Management of Oncological, Cardiovascular and Infectious Diseases, Particularly Tuberculosis”.
2. IAEA TC Project “Capacity Building for the Clinical Application of PET-CT, Cyclotron Operation and PET Radiopharmaceutical Production” (2018-19).

IAEA RCA Project:
1. Strengthening the effectiveness and extent of Medical Physics Education and Training (RAS/6/077).
2. Improving Cancer Management with Hybrid Nuclear Medicine Imaging (RAS/6/061)
3. Building Capacity with Distance Assisted Training For Nuclear Medicine Professionals (RAS/6/064).
4. Strengthening Hybrid Imaging in Nuclear Medicine in Asia and Pacific Region (RAS/6/079).
5. Supporting Comprehensive Cancer Control in the Asia and the Pacific Region (RAS/6/069).
6. Strengthening Nuclear Medicine Diagnostic and Therapeutic Applications in Oncology in the Asia region (RAS/6/067).

CRP (Coordinated Research Project with IAEA) Project:
1. CRP Project E15021 “FDG PET/CT in the evaluation of Extra-pulmonary Tuberculosis and Response of Therapy”.
2. Development of Quantitative Nuclear Medicine Imaging for Optimized Patient Specific Dosimetry (E2.10.07).
3. Doctoral CRP Project E2.40.19 “Advances in Medical Imaging Techniques”
4. PET-CT in the management of pediatric lymphoma (E-12017).

1. Government ADP project “Establishment of Positron Emission Tomography Computed Tomography (PET-CT) Technology with Cyclotron facilities”.
2. Government ADP project “Upgrading and strengthening the facilities at National Institute of Nuclear Medicine and Allied Sciences (Former INMU)".

IN-HOUSE Project:
1. Evaluation of PET-CT in gastrointestinal carcinoma
2. Role of PET-CT in evaluation of treatment response in lung carcinoma
3. Experience of PET-CT in adult lymphoma.
4. Duplex study of vertebral arteries in patients.
5. Assessment of carotid vessels in DM and TIA.
6. Musculo skeletal ultrasonography of different limb joints and injury.
7. Duplex study of uterine artery to predict pre- eclampsia. Case- control study.
8. Duplex study of penile vessels in erectile dysfunction. (Pharmaceutical augmented).
9. Less fetal movements and oligohydraamnios associated with high S/D ratio of umbilical artery.
10. Influence of high antiTg antibody in treatment outcome and follow up of radioiodine treated thyroid carcinoma patients.
11. Assessment of outcome of hyperthyroid patients who needed more than single dose of radioiodine
12. Spectrum of thyroid dysfunction in children who are referred to NINMAS for thyroid function evaluation

Institutional Medical Research Ethics Committee (MREC) was formed on 2014 at NINMAS including 15 expert members of different disciplines. By 2016, five meetings are held on submitted projects. So far 17 projects have got ethical approval by MREC after reviewing.